2-(3-(3,5-DIMETHOXYPHENOXY)PROPYL)ISOINDOLINE-1,3-DIONE, 95.0%, 1g

{[4-(1H-benzimidazol-2-yl)cyclohexyl]methyl}amine dihydrochloride, 95.0%, 1g

2-Chloropyrimidine-4,6-dicarbonitrile, 97.0%, 250mg

(7R,8aS)-2-benzyl-7-hydroxy-octahydropyrrolo[1,2-a]piperazine-1,4-dione, 95.0%, 250mg

1-Ethoxy-2,4-dinitrobenzene, 98%, 1g

(3-(Trifluoromethyl)pyrrolidin-3-yl)methanol, 1g

(5-Bromo-2-methylpyridin-3-yl)methanol, 97%, 1g

6-Chloro-3-iodo-[1,2,4]triazolo[4,3-a]pyridine, 98%, 500mg

(S)-di-tert-butyl 2-carbamoylpiperazine-1,4-dicarboxylate, 97%, 100mg

2,7-Di(9H-carbazol-9-yl)-9,9'-spirobi[fluorene], 98%, 10g

N,N-dimethylacetamide, min. 99%, for synthesis, 10 l, plastic packaging.

Methyl 1H-pyrrolo[3,2-b]pyridine-5-carboxylate, 95.0%, 500mg

L-1-Fmoc-Nipecotic acid, 97.0%, 5g